Advertisement
MS vs NMR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MS is a Buy and NMR is a Hold.
Momentum Indicator for MS turns positive, indicating new upward trend
MS saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned positive. In 54 of the 73 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MS's RSI Indicator exited the oversold zone, 15 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for MS just turned positive on October 21, 2026. Looking at past instances where MS's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in 230 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for MS entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 17 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.800) is normal, around the industry mean (3.456). P/E Ratio (15.200) is within average values for comparable stocks, (8.942). Projected Growth (PEG Ratio) (1.702) is also within normal values, averaging (0.809). Dividend Yield (0.024) settles around the average of (7.442) among similar stocks. P/S Ratio (4.380) is also within normal values, averaging (16.763).
NMR's RSI Oscillator climbs out of oversold territory
The RSI Indicator for NMR moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 20 of the 27 cases the stock moved higher. This puts the odds of a move higher at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 61 cases where NMR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on NMR as a result. In 56 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for NMR just turned positive on October 29, 2026. Looking at past instances where NMR's MACD turned positive, the stock continued to rise in 33 of 48 cases over the following month. The odds of a continued upward trend are 69%.
Following a +3.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where NMR advanced for three days, in 206 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
NMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
NMR moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NMR crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
The Aroon Indicator for NMR entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.007) is normal, around the industry mean (3.456). P/E Ratio (0.069) is within average values for comparable stocks, (8.942). Projected Growth (PEG Ratio) (0.815) is also within normal values, averaging (0.809). Dividend Yield (0.040) settles around the average of (7.442) among similar stocks. P/S Ratio (2.472) is also within normal values, averaging (16.763).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
MS | NMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 17 | 18 | |
SMR RATING 1..100 | 5 | 1 | |
PRICE GROWTH RATING 1..100 | 55 | 51 | |
P/E GROWTH RATING 1..100 | 56 | 97 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NMR's Valuation (79) in the Investment Banks Or Brokers industry is in the same range as MS (92). This means that NMR’s stock grew similarly to MS’s over the last 12 months.
MS's Profit vs Risk Rating (17) in the Investment Banks Or Brokers industry is in the same range as NMR (18). This means that MS’s stock grew similarly to NMR’s over the last 12 months.
NMR's SMR Rating (1) in the Investment Banks Or Brokers industry is in the same range as MS (5). This means that NMR’s stock grew similarly to MS’s over the last 12 months.
NMR's Price Growth Rating (51) in the Investment Banks Or Brokers industry is in the same range as MS (55). This means that NMR’s stock grew similarly to MS’s over the last 12 months.
MS's P/E Growth Rating (56) in the Investment Banks Or Brokers industry is somewhat better than the same rating for NMR (97). This means that MS’s stock grew somewhat faster than NMR’s over the last 12 months.
| MS | NMR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 58% | 1 day ago 67% |
| Momentum ODDS (%) | 1 day ago 74% | 1 day ago 68% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 69% |
| TrendWeek ODDS (%) | 1 day ago 66% | 1 day ago 65% |
| TrendMonth ODDS (%) | 1 day ago 58% | 1 day ago 55% |
| Advances ODDS (%) | 3 days ago 65% | 1 day ago 68% |
| Declines ODDS (%) | 8 days ago 60% | 8 days ago 54% |
| BollingerBands ODDS (%) | 1 day ago 70% | 1 day ago 55% |
| Aroon ODDS (%) | 1 day ago 54% | 1 day ago 56% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MS’s FA Score shows that 2 FA rating(s) are green while NMR’s FA Score has 2 green FA rating(s).
- MS’s FA Score: 2 green, 3 red.
- NMR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MS’s TA Score shows that 5 TA indicator(s) are bullish while NMR’s TA Score has 6 bullish TA indicator(s).
- MS’s TA Score: 5 bullish, 3 bearish.
- NMR’s TA Score: 6 bullish, 4 bearish.
Price Growth
MS (@Investment Banks/Brokers) experienced а +3.28% price change this week, while NMR (@Investment Banks/Brokers) price change was +4.76% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was +39.29%. For the same industry, the average monthly price growth was +0.76%, and the average quarterly price growth was -17.56%.
Reported Earning Dates
MS is expected to report earnings on Jan 14, 2027.
NMR is expected to report earnings on Feb 03, 2027.
Industries' Descriptions
@Investment Banks/Brokers (+39.29% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
Advertisement
MS and
Correlation & Price change
A.I.dvisor indicates that over the last year, MS has been closely correlated with GS. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if MS jumps, then GS could also see price increases.
NMR and
Correlation & Price change
A.I.dvisor indicates that over the last year, NMR has been loosely correlated with MS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NMR jumps, then MS could also see price increases.